And I'm guessing that the FDA, MHRA and other agencies are involved in this " scam"? The FDA is past reviewing Leronlimab and as stated in the PR, talk are being held. I guess we'll wait and see? We'll see who the winners are and who ( just a few) the losers will be. I know one thing thats a fact- Cytodyn is up over 300 percent YTD- not bad huh? Oh, another thing, institutions are buying in as well. Question for you, do you think that the large institutions buying in have not dome their due diligence?
Market Data 
Markets 
AI
